Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kaori Sano, Akira Ainai, Tadaki Suzuki & Hideki Hasegawa. (2018) Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics. Expert Review of Vaccines 17:8, pages 687-696.
Read now
Read now
Yoshihiko Terauchi, Kaori Sano, Akira Ainai, Shinji Saito, Yuki Taga, Kiyoko Ogawa-Goto, Shin-ichi Tamura, Takato Odagiri, Masato Tashiro, Mikiya Fujieda, Tadaki Suzuki & Hideki Hasegawa. (2018) IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration. Human Vaccines & Immunotherapeutics 14:6, pages 1351-1361.
Read now
Read now
Takeshi Ichinohe, Akiko Iwasaki & Hideki Hasegawa. (2008) Innate sensors of influenza virus: clues to developing better intranasal vaccines. Expert Review of Vaccines 7:9, pages 1435-1445.
Read now
Read now
Articles from other publishers (21)
Kaori Sano, Shinji Saito, Tadaki Suzuki, Osamu Kotani, Akira Ainai, Elly van Riet, Koshiro Tabata, Kumpei Saito, Yoshimasa Takahashi, Masaru Yokoyama, Hironori Sato, Takahiro Maruno, Kaede Usami, Susumu Uchiyama, Kiyoko Ogawa-Goto & Hideki Hasegawa. (2021) An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody. PLOS ONE 16:1, pages e0245244.
Crossref
Crossref
Tamiru Negash Alkie, Alexander Yitbarek, Khaled Taha-Abdelaziz, Jake Astill & Shayan Sharif. (2018) Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens. PLOS ONE 13:11, pages e0206324.
Crossref
Crossref
Valentina Bernasconi, Beatrice Bernocchi, Liang Ye, Minh Quan Lê, Ajibola Omokanye, Rodolphe Carpentier, Karin Schön, Xavier Saelens, Peter Staeheli, Didier Betbeder & Nils Lycke. (2018) Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections. Frontiers in Immunology 9.
Crossref
Crossref
Nermeen M. Ismail, Ayman H. El-Deeb, Mohamed M. Emara, Hoda I. Tawfik, Nabil Abdel Wanis & Hussein A. Hussein. (2018) IMS 1313-nanoparticle Mucosal Vaccine Enhances Immunity Against Avian Influenza and Newcastle Disease Viruses. International Journal of Poultry Science 17:4, pages 167-174.
Crossref
Crossref
Kaori Sano, Akira Ainai, Tadaki Suzuki & Hideki Hasegawa. (2017) The road to a more effective influenza vaccine: Up to date studies and future prospects. Vaccine 35:40, pages 5388-5395.
Crossref
Crossref
Keiya Muto, Noriyasu Kamei, Mia Yoshida, Kozo Takayama & Mariko Takeda-Morishita. (2016) Cell-Penetrating Peptide Penetratin as a Potential Tool for Developing Effective Nasal Vaccination Systems. Journal of Pharmaceutical Sciences 105:6, pages 2014-2017.
Crossref
Crossref
Shinji Saito, Akira Ainai, Tadaki Suzuki, Norihiro Harada, Yasushi Ami, Yoshikazu Yuki, Haruko Takeyama, Hiroshi Kiyono, Hideo Tsukada & Hideki Hasegawa. (2016) The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine. Vaccine 34:9, pages 1201-1207.
Crossref
Crossref
Han Lei, Xiaojue Peng, Jiexiu Ouyang, Daxian Zhao, Huifeng Jiao, Handing Shu & Xinqi Ge. (2015) Intranasal immunization of recombinant Lactococcus lactis induces protection against H5N1 virus in ferrets. Virus Research 196, pages 56-59.
Crossref
Crossref
. (2013) インフルエンザ・ワクチンについて. Juntendo Medical Journal 59:1, pages 41-48.
Crossref
Crossref
Angela Henderson, Katie Propst, Ross Kedl & Steven Dow. (2011) Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity. Vaccine 29:32, pages 5304-5312.
Crossref
Crossref
Lea Torrieri-Dramard, Bénédicte Lambrecht, Helena Lage Ferreira, Thierry Van den Berg, David Klatzmann & Bertrand Bellier. (2011) Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses. Molecular Therapy 19:3, pages 602-611.
Crossref
Crossref
Takeshi Ichinohe, Akira Ainai, Yasushi Ami, Noriyo Nagata, Naoko Iwata, Akira Kawaguchi, Yuriko Suzaki, Takato Odagiri, Masato Tashiro, Hidehiro Takahashi, David R. Strayer, William A. Carter, Joe Chiba, Shin-ichi Tamura, Tetsutaro Sata, Takeshi Kurata & Hideki Hasegawa. (2010) Intranasal administration of adjuvant-combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus. Journal of Medical Virology 82:10, pages 1754-1761.
Crossref
Crossref
Peter T. Loudon, Eric J. Yager, Debbie T. Lynch, Amithi Narendran, Cristy Stagnar, Anthony M. Franchini, James T. Fuller, Phil A. White, Julia Nyuandi, Clayton A. Wiley, Michael Murphey-Corb & Deborah H. Fuller. (2010) GM-CSF Increases Mucosal and Systemic Immunogenicity of an H1N1 Influenza DNA Vaccine Administered into the Epidermis of Non-Human Primates. PLoS ONE 5:6, pages e11021.
Crossref
Crossref
Kouta Sakamoto, Hideki Asanuma, Tomoyuki Nakamura, Takayuki Kanno, Tetsutaro Sata & Harutaka Katano. (2010) Immune response to intranasal and intraperitoneal immunization with Kaposi's sarcoma-associated herpesvirus in mice. Vaccine 28:19, pages 3325-3332.
Crossref
Crossref
Eric J. Yager, Cristy Stagnar, Ragisha Gopalakrishnan, Anthony Franchini, Amithi Narendran, James T. Fuller & Deborah H. Fuller. (2010) Particle-mediated DNA vaccines against seasonal and pandemic influenza viruses elicit strong mucosal antibody and T cell responses in the lung. Procedia in Vaccinology 3, pages 2-11.
Crossref
Crossref
Takeshi Ichinohe, Akira Ainai, Masato Tashiro, Tetsutaro Sata & Hideki Hasegawa. (2009) PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants. Vaccine 27:45, pages 6276-6279.
Crossref
Crossref
Hiroyuki Kayamuro, Yasuhiro Abe, Yasuo Yoshioka, Kazufumi Katayama, Tetsuya Nomura, Tokuyuki Yoshida, Kohei Yamashita, Tomoaki Yoshikawa, Yuichi Kawai, Tadanori Mayumi, Takachika Hiroi, Norio Itoh, Kazuya Nagano, Haruhiko Kamada, Shin-ichi Tsunoda & Yasuo Tsutsumi. (2009) The use of a mutant TNF-α as a vaccine adjuvant for the induction of mucosal immune responses. Biomaterials 30:29, pages 5869-5876.
Crossref
Crossref
Pan TaoMengcheng LuoDandan Zhu, Sanfu Qu, Zhenhua Yang, Meng Gao, Deyin Guo & Zishu Pan. (2009) Virus-Like Particle Vaccine Comprised of the HA, NA, and M1 Proteins of an Avian Isolated H5N1 Influenza Virus Induces Protective Immunity Against Homologous and Heterologous Strains in Mice. Viral Immunology 22:4, pages 273-281.
Crossref
Crossref
Yan Yue, Wei Xu, Linkun Hu, Zhenggang Jiang & Sidong Xiong. (2009) Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle. Virology 386:2, pages 438-447.
Crossref
Crossref
Taisuke Horimoto & Yoshihiro Kawaoka. 2009. Vaccines for Pandemic Influenza. Vaccines for Pandemic Influenza
165
176
.
Mark von Itzstein. (2007) The war against influenza: discovery and development of sialidase inhibitors. Nature Reviews Drug Discovery 6:12, pages 967-974.
Crossref
Crossref